Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TEVA News
Goldman Sachs Identifies Compelling Stocks Amid Market Volatility
1d ago
CNBC
Harel Insurance Sells KBWB ETF Shares Worth $330 Million
Feb 05 2026
Fool
Harel Insurance Sells $330 Million in KBWB Shares
Feb 05 2026
NASDAQ.COM
Stan Druckenmiller: The Influential Figure Behind Bessent and Warsh, Potential Candidates for Fed Chair
Feb 02 2026
Barron's
Teva Pharmaceutical Stock Surges Nearly 400% Post-Leader Change
Jan 31 2026
Yahoo Finance
Deckers Stock Soars After Surprising Q3 Earnings Beat
Jan 31 2026
Yahoo Finance
Novo Nordisk Accused of Victoza Monopoly Extension
Jan 30 2026
Benzinga
Teva Pharmaceutical Shares Dip After Six-Day Rally Amid Cautious Outlook
Jan 29 2026
seekingalpha
Teva Pharmaceutical Q4 2025 Earnings Exceed Expectations
Jan 28 2026
Benzinga
Teva Pharmaceutical Exceeds Q4 2025 Expectations but Projects Lower 2026 Financials
Jan 28 2026
seekingalpha
Teva Pharmaceutical Exceeds Expectations, Transitioning to Growth Story
Jan 28 2026
seekingalpha
Teva Pharmaceuticals to Host Q4 2025 Earnings Call
Jan 28 2026
NASDAQ.COM
Teva Pharmaceutical Q4 Earnings Exceed Expectations
Jan 28 2026
seekingalpha
Teva Pharmaceuticals to Announce Q4 Earnings on January 28
Jan 27 2026
seekingalpha
Novo Nordisk Accused of Pay-for-Delay Scheme with Teva to Block Generic Victoza
Jan 24 2026
seekingalpha
Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes
Jan 16 2026
NASDAQ.COM
Show More News
